Finland to India: Strip Import Trade Route

The Finland to India Strip corridor is one of India's established pharmaceutical import routes from Finland, with 12 shipments documented worth a combined $171.8M USD. The route is dominated by NEXTPHARMA OY , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Finland's strip export sector.

Across 2 active Finland suppliers, the average shipment value stands at $14.3M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with strip's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 28.9%, placing it at rank #9 among India's top strip import origins globally.

On the Indian buyer side, key Indian importers include SOMERSET THERAPEUTICS LIMITED , SOMERSET THERAPEUTICS PRIVATE LIMITED. SOMERSET THERAPEUTICS LIMITED is the single largest Indian importer with 2 shipments valued at $171.8M USD.

India's strip imports from Finland are driven primarily by a handful of large-scale Finland manufacturers. NEXTPHARMA OY with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — Indian buyers benefit from Finland supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NEXTPHARMA OY , NEXTPHARMA OY — together account for 100% of total trade value on this route. The average shipment value of $14.3M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as (foc - sample for testing) - dev tafluprost 0.0015% ud som pouched ampoule strips 200 pce - 3047691 and (foc - samples for testing) - dev dorzolamide 2% timolol 0.5% som, pouched ampoule strips - fp 325762 / sfp 325724(foc - samples for testing) - dev dorzolamide 2% timolol 0.5, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Finland supplier.

On the buying side, SOMERSET THERAPEUTICS LIMITED is the largest importer with 2 shipments worth $171.8M USD — representing 100% of all strip imports from Finland on this route.